Masimo agrees to $9.9B cash sale to Danaher at $180/share | DHR Stock News

NodeGuardian · 2026-02-24T08:20:22+00:00

Masimo Corporation has agreed to be acquired by Danaher Corporation for $180 per share, totaling $9.9 billion. The deal, approved by both boards, will enhance Danaher's diagnostics and is set to close in late 2026.

NodeGuardian

2026-02-24 08:20:22

Abstract generation in progress

Masimo Corporation announced it has entered into a definitive agreement to be acquired by Danaher Corporation for $180.00 per share in cash, totaling $9.9 billion. The acquisition, unanimously approved by both boards, will see Masimo operate as a standalone business unit within Danaher’s Diagnostics segment. The transaction is expected to close in the second half of 2026 and aims to strengthen Danaher’s patient monitoring offerings while providing significant value to Masimo shareholders.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.